Argus
•
Apr 15, 2026
AVTR: What does Argus have to say about AVTR?
Summary
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced t
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Bio-Rad Laboratories, Inc.
May 01, 2026
•
BIO
APLS: What does Argus have to say about APLS?
Apr 29, 2026
•
APLS
AXTA: Lowering target price to $27.00
Apr 29, 2026
•
AXTA
BIO: Lowering target price to $265.00
Apr 29, 2026
•
BIO
BRKR: Lowering target price to $34.00
Apr 29, 2026
•
BRKR
